Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vas Narasimhan
Pharma
Novartis gears up for key expansions of 3 cancer drugs
Pluvicto, Ksiqali and Scemblix have key new indications lined up for them in earlier treatment settings. But they all slightly disappointed in Q1.
Angus Liu
Apr 23, 2024 3:37pm
Novartis reviews ties to China amid US biosecurity crackdown
Apr 23, 2024 11:07am
Big Pharma CEOs offer China renewed interest, policy advice
Mar 26, 2024 11:46am
PhRMA taps Gilead CEO Dan O'Day as its new board chair
Feb 21, 2024 2:51pm
Novartis CEO's pay rises 21% as Roche's new chief nets $11M
Feb 5, 2024 1:28pm
JPM24: Novartis CEO explains how he's resisted ADC temptation
Jan 8, 2024 3:23pm